| Structure |
Chemical Name |
CAS |
MF |
 |
Cefuroxime double mother nucleus |
|
|
 |
6α,9α-difluoro-17α-(furan-2-yl)carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioic acid |
397864-40-3 |
C26H28F2O6S |
 |
Derivatives intermediate 2 |
1213710-57-6 |
C26H38N2O3 |
 |
Lixivaptan intermediate-IV |
179063-21-9 |
C19H14ClN3O3 |
![(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate](/CAS/20180702/GIF/167271-60-5.gif) |
(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate |
167271-60-5 |
C14H13N5O3S |
![N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide](/CAS/20180702/GIF/1383385-64-5.gif) |
N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide |
1383385-64-5 |
C18H21BN2O3 |
![tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate](/CAS/20200119/GIF/1201187-44-1.gif) |
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate |
1201187-44-1 |
C18H20N4O4S |
![5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid](/CAS/20180906/GIF/1422956-25-9.gif) |
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid |
1422956-25-9 |
C28H31ClN4O3 |
 |
Dmt-2'fluoro-da(bz) amidite |
136834-22-5 |
C47H51FN7O7P |
 |
1,4-bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-dione |
1292836-19-1 |
C16H8Cl2F2N2O6 |
 |
Isavuconazole Impurity |
338990-63-9 |
C40H43ClF2N8O7S |
 |
5-Methacroyloxy-2,6-norbornane carbolactone |
254900-07-7 |
C12H14O4 |
 |
Eribulin intermediateB |
|
|
 |
(S)-5-fluoro-3-methylisobenzofuran-1(3H)-one |
1803573-19-4 |
C9H7FO2 |
 |
(4-Fluoro-phenyl)-piperidin-4-yl-amine dihydrochloride |
1193389-70-6 |
C11H17Cl2FN2 |
 |
6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine |
67287-53-0 |
C19H22ClNO3 |
 |
Phosphonic acid, (3-methyloxiranyl)-, (2R-cis)-, compd. with (R)-alpha-methylbenzenemethanamine (1:1), monohydrate (9CI) |
65794-75-4 |
C11H18NO4P |
 |
4-methyl-8-nitro-2H- chromen-2-one |
184290-97-9 |
C10H7NO4 |
 |
ECHINOCANDIN B |
79411-15-7 |
C34H51N7O15 |
![1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE](/CAS/GIF/197897-11-3.gif) |
1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE |
197897-11-3 |
C14H14IN5O3S |
 |
METHYL 5-BROMO-3-HYDROXYBENZOATE |
192810-12-1 |
C8H7BrO3 |
 |
Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate |
154330-67-3 |
C14H13F2NO3S |
 |
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid |
79276-23-6 |
C15H25N3O6 |
![(3R,3αS,6αR)-Hexahydrofuro[2,3-β]furan-3-yl-4-nitrophenyl carbonate](/CAS/20180808/GIF/252873-35-1.gif) |
(3R,3αS,6αR)-Hexahydrofuro[2,3-β]furan-3-yl-4-nitrophenyl carbonate |
252873-35-1 |
C13H13NO7 |
![3-Azabicyclo[3.1.0]hexane-1,3-dicarboxylic acid, 3-(1,1-dimethylethyl) 1-ethyl](/CAS/GIF/1204820-62-1.gif) |
3-Azabicyclo[3.1.0]hexane-1,3-dicarboxylic acid, 3-(1,1-dimethylethyl) 1-ethyl |
1204820-62-1 |
C13H21NO4 |
 |
Cefovecin |
234096-34-5 |
C17H19N5O6S2 |
 |
tert-butyl (3S,4R)-4-aMino-3-fluoropiperidine-1-carboxylate |
907544-20-1 |
C10H19FN2O2 |
 |
Oseltamivir Fructose Adduct 1 |
|
C22H38N2O9 |
 |
α-Pseudouridine |
10017-66-0 |
C9H12N2O6 |
 |
Cephalexin ethyl homologue |
|
|
 |
Boc-His(Trt)-Aib-Glu(Otbu)-Gly-OH |
1890228-73-5 |
C45H56N6O9 |
 |
tert-butyl (R)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240586-07-5 |
C11H19F3N2O2 |
 |
Aztreonam and Arginine Polymerization Impurity 2 |
|
|
 |
Canagliflozin Intermediate epimers |
|
|
![8-Methylene-1,4-dioxa-spiro[4.5]decane](/StructureFile/ChemBookStructure9/GIF/CB1767597.gif) |
8-Methylene-1,4-dioxa-spiro[4.5]decane |
51656-90-7 |
C9H14O2 |
 |
(3R,4S,5S)-Oseltamivir |
|
|
![1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-5-[[(1,1-dimethylethoxy)carbonyl]hydroxyamino]-5,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,5R)-](/CAS/20211123/GIF/2209872-72-8.gif) |
1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-5-[[(1,1-dimethylethoxy)carbonyl]hydroxyamino]-5,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,5R)- |
2209872-72-8 |
C17H29N3O6 |
 |
(Ac)Phe-Lys(Alloc)-PABC-PNP |
2070009-39-9 |
C35H39N5O10 |
 |
(9H-fluoren-9-yl)methyl ((2S,3R)-3-hydroxy-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
 |
Etodesnitazene |
14030-76-3 |
C22H29N3O |
![1,4-BIS-[4-(6-ACRYLOYLOXYHEXYLOXY)BENZOYLOXY]-2-METHYLBENZENE](/CAS/GIF/125248-71-7.gif) |
1,4-BIS-[4-(6-ACRYLOYLOXYHEXYLOXY)BENZOYLOXY]-2-METHYLBENZENE |
125248-71-7 |
C39H44O10 |
 |
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one |
156732-13-7 |
C32H32N2O |
 |
pinanyl hydroperoxide |
28324-52-9 |
C10H18O2 |
![iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide](/CAS/GIF/76247-39-7.gif) |
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide |
76247-39-7 |
C9H12INO5S |
 |
Intermediate 1 |
2203433-07-0 |
C17H16N2O5 |
 |
8-bromoxanthosine |
3001-46-5 |
C10H11BrN4O6 |
 |
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
1062580-52-2 |
C14H23ClN2 |
![2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2H-pyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methyl-1H-indazol-5-yl)-1,3-dihydro-](/CAS/20210305/GIF/2212022-56-3.gif) |
2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2H-pyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methyl-1H-indazol-5-yl)-1,3-dihydro- |
2212022-56-3 |
C26H25F2N7O |
 |
Amic acid |
|
|
 |
Mesalazine-13C6 |
1189709-96-3 |
C7H7NO3 |
 |
Lauroyl-L-carnitine |
25518-54-1 |
C19H37NO4 |
 |
ATORVASTATIN SODIUM |
134523-01-6 |
C33H36FN2NaO5 |
 |
N(4)-methylcytidine |
10578-79-7 |
C10H15N3O5 |
 |
qianhucoumarin A |
150135-35-6 |
C19H20O6 |
 |
5-BROMOCYTIDINE |
3066-86-2 |
C9H12BrN3O5 |
 |
4-Chlorobenzil |
22711-23-5 |
C14H9ClO2 |
![3,6-Diazabicyclo[3.1.1]heptane-6-carboxylic acid, 3-[5-[3-cyano-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridin-4-yl]-2-pyridinyl]-, 1,1-dimethylethyl ester](/CAS/20210111/GIF/2222755-94-2.gif) |
3,6-Diazabicyclo[3.1.1]heptane-6-carboxylic acid, 3-[5-[3-cyano-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridin-4-yl]-2-pyridinyl]-, 1,1-dimethylethyl ester |
2222755-94-2 |
C27H32N6O4 |
 |
2-Bromo-1-phenyl-pentan-1-one |
49851-31-2 |
C11H13BrO |
![(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride](/CAS/GIF/171752-68-4.gif) |
(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride |
171752-68-4 |
C20H19ClN2O4 |
 |
didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate |
36265-41-5 |
C33H59NO4 |
 |
Oseltamivir Fructose Adduct 5 |
|
|
 |
Oseltamivir Glucose Adduct 3 |
|
|
 |
Flubrotizolam |
57801-95-3 |
C15H10BrFN4S |
 |
cefaloram |
859-07-4 |
C18H18N2O6S |
 |
tert-butyl (R)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate |
|
|
 |
tert-butyl (E)-4-bromo-3-(4-ethoxy-4-oxobut-2-en-1-yl)thiophene-2-carboxylate |
|
|
 |
C20-Glu-AEEA-AEEA-OSU |
|
|
 |
tert-butyl (R)-4-((benzyloxy)methyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
|
|
 |
Levofloxacin R-Isomer HCl |
|
|
 |
1-Isopropylimidazole |
4532-96-1 |
C6H10N2 |
![2-[1-(trichlorostannyl)propyl]-Benzothiazole](/CAS/20210305/GIF/111982-00-4.gif) |
2-[1-(trichlorostannyl)propyl]-Benzothiazole |
111982-00-4 |
C10H10Cl3NSSn |
 |
4-BROMO-5-METHYL-1H-INDAZOLE |
926922-40-9 |
C8H7BrN2 |
![TERT-BUTYL 2,8-DIAZASPIRO[4.5]DECAN-2-CARBOXYLATE HYDROCHLORIDE](/CAS/GIF/869976-20-5.gif) |
TERT-BUTYL 2,8-DIAZASPIRO[4.5]DECAN-2-CARBOXYLATE HYDROCHLORIDE |
869976-20-5 |
C13H24N2O2.HCl |
 |
ethyl 2-amino-4-(3-chlorophenyl)thiophene-3-carboxylate |
473438-03-8 |
C13H12ClNO2S |
 |
5-(2-chloroethyl)-2,3-dihydrobenzofuran |
943034-50-2 |
C10H11ClO |
 |
5-METHYLINDOLE-3-CARBOXYLIC ACID METHYL ESTER |
227960-12-5 |
C11H11NO2 |
 |
cis-Pinane |
6876-13-7 |
C10H18 |
 |
AURORA KA-1056 |
224313-74-0 |
C10H8N2O4 |
 |
Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
161798-01-2 |
C14H13NO4S |
 |
5-Ethyl-2H-pyrazole-3-carboxylic acid ethyl ester |
26308-40-7 |
C8H12N2O2 |
 |
(R)-1-Boc-3-hydroxypyrrolidine |
109431-87-0 |
C9H17NO3 |
 |
PROSTAGLANDIN F1ALPHA |
745-62-0 |
C20H36O5 |
 |
Boceprevir InterMediates |
565456-77-1 |
C9H16ClNO2 |
 |
3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride |
188416-20-8 |
C16H14Cl2F3N5O |
![Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-, methyl ester](/CAS2/GIF/153559-48-9.gif) |
Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-, methyl ester |
153559-48-9 |
C25H30O2 |
 |
3-Iodo-1H-pyrazole-4-carboxylic acid ethyl ester |
827316-43-8 |
C6H7IN2O2 |
 |
(R)-(2-Aminomethyl)-1-N-Boc-pyrrolidine HCl |
1190890-12-0 |
C10H21ClN2O2 |
 |
4-Androsten-3b-ol-17-one |
571-44-8 |
C19H28O2 |
 |
(3R,5R)-1-Boc-3,5-diMethylpiperazine |
438049-91-3 |
C11H22N2O2 |
 |
7-hydroxy-4-Methyl-2-oxo-2H-1-Benzopyran-8-carboxaldehyde |
14003-96-4 |
C11H8O4 |
 |
Cyclopropanecarboxylic acid, 1-aMino-, 1,1-diMethylethyl ester |
159871-51-9 |
C8H15NO2 |
 |
(2S,5R)-ethyl 5-(benzyloxyaMino)piperidine-2-carboxylate |
1416134-47-8 |
C15H22N2O3 |
![1-[(2S)-2-(benzyloxy)propanoyl]pyrrolidine](/CAS/20150408/GIF/122151-32-0.gif) |
1-[(2S)-2-(benzyloxy)propanoyl]pyrrolidine |
122151-32-0 |
C14H19NO2 |
 |
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran |
915095-94-2 |
C17H16ClIO2 |
 |
4-Amino-3-chlorophenol |
17609-80-2 |
C6H6ClNO |
![4-Chloro-benzenesulfonic acid 5-(2,4-difluoro-phenyl)-5-[1,2,4]triazol-1-ylMethyl-tetrahydro-furan-3-ylMethyl ester](/CAS/20150408/GIF/175712-02-4.gif) |
4-Chloro-benzenesulfonic acid 5-(2,4-difluoro-phenyl)-5-[1,2,4]triazol-1-ylMethyl-tetrahydro-furan-3-ylMethyl ester |
175712-02-4 |
C20H18ClF2N3O4S |
 |
Coumarin |
6160-02-7 |
C19H19NO2 |
 |
4,4'-(Hexafluoroisopropylidene)diphthalic anhydride |
1107-00-2 |
C19H6F6O6 |
 |
Nevirapine intermediate |
|
|
 |
Fluvis group intermediate |
|
|